يعرض 61 - 70 نتائج من 136 نتيجة بحث عن '"(1"', وقت الاستعلام: 1.02s تنقيح النتائج
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65
  6. 66

    المساهمون: Les Hôptaux universitaires de Strasbourg (HUS), CHU Strasbourg, Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Equipe 11, Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Centre Léon Bérard [Lyon], Service d'Oncologie Médicale, Equipe 1, Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Service d'Oncologie Médicale, Département d'anatomopathologie, biopathologie, Service d'Anatomopathologie, Altération génétique des cancers, chimioprévention et réponse thérapeutique

    المصدر: European Journal of Cancer
    European Journal of Cancer, Elsevier, 2012, 48 (16), pp.3027-35. ⟨10.1016/j.ejca.2012.05.009⟩

    مصطلحات موضوعية: Male, Cancer Research, Pathology, Time Factors, MESH: Osteosarcoma, Receptor, ErbB-2, medicine.medical_treatment, Biopsy, Kaplan-Meier Estimate, MESH: Antibodies, Monoclonal, Receptor, IGF Type 1, MESH: Biopsy, Insulin-like growth factor, MESH: Receptor, IGF Type 1, 0302 clinical medicine, MESH: Child, Epidermal growth factor receptor, Child, MESH: Treatment Outcome, MESH: Aged, 0303 health sciences, Osteosarcoma, MESH: Middle Aged, Antibodies, Monoclonal, MESH: Insulin-Like Growth Factor Binding Protein 3, Sarcoma, Middle Aged, MESH: Bone Neoplasms, Immunohistochemistry, MESH: Predictive Value of Tests, MESH: Sarcoma, Ewing, 3. Good health, ErbB Receptors, Treatment Outcome, Oncology, MESH: Receptor, erbB-2, MESH: Young Adult, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, France, MESH: Ki-67 Antigen, MESH: Cell Nucleus, Adult, medicine.medical_specialty, MESH: Cell Line, Tumor, Adolescent, [SDV.CAN]Life Sciences [q-bio]/Cancer, Antineoplastic Agents, Bone Neoplasms, MESH: Receptor, Epidermal Growth Factor, Sarcoma, Ewing, Biology, Disease-Free Survival, 03 medical and health sciences, Young Adult, Predictive Value of Tests, Cell Line, Tumor, medicine, Biomarkers, Tumor, Humans, MESH: Patient Selection, Progression-free survival, MESH: Kaplan-Meier Estimate, 030304 developmental biology, Aged, MESH: Adolescent, Cell Nucleus, MESH: Humans, Growth factor, Patient Selection, MESH: Time Factors, MESH: Adult, MESH: Immunohistochemistry, medicine.disease, MESH: Male, MESH: France, Insulin-Like Growth Factor Binding Protein 3, Ki-67 Antigen, MESH: Disease-Free Survival, MESH: Sarcoma, MESH: Tumor Markers, Biological, Cancer research, biology.protein, MESH: Antineoplastic Agents, MESH: Female, Immunostaining

  7. 67
  8. 68
  9. 69
  10. 70